Xuzhou Medical University is a provincial university located in Xuzhou, Jiangsu Province, China.

During the past decade, The Affiliated Hospital of Xuzhou Medical University conducted 146 clinical trials. In the 10-year time frame, 146 clinical trials started and 12 clinical trials were completed, i.e. on average, 8.2% percent of trials that started reached the finish line to date. In the past 5 years, 94 clinical trials started and 9 clinical trials were completed. i.e. 9.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Affiliated Hospital of Xuzhou Medical University" #1 sponsor was "The Affiliated Hospital of Xuzhou Medical University" with 22 trials, followed by "BeiGene" with 12 trials sponsored, "Xuzhou Medical University" with 12 trials sponsored, "Hoffmann-La Roche" with 7 trials sponsored and "Kai Lin Xu; Jun Nian Zheng" with 7 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 85 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Affiliated Hospital of Xuzhou Medical University" #1 collaborator was "The Affiliated Hospital of Xuzhou Medical University" with 9 trials as a collaborator, "Xuzhou Medical University" with 6 trials as a collaborator, "West China Hospital" with 4 trials as a collaborator, "Cancer Institute and Hospital, Chinese Academy of Medical Sciences" with 3 trials as a collaborator and "First Affiliated Hospital Xi'an Jiaotong University" with 3 trials as a collaborator. Other collaborators include 216 different institutions and companies that were collaborators in the rest 192 trials.

According to Clinical.Site data, the most researched conditions in "The Affiliated Hospital of Xuzhou Medical University" are "Acute Ischemic Stroke" (5 trials), "Chronic Heart Failure" (4 trials), "Chronic Lymphocytic Leukemia" (4 trials), "Chronic Hepatitis B" (3 trials) and "Esophageal Squamous Cell Carcinoma" (3 trials). Many other conditions were trialed in "The Affiliated Hospital of Xuzhou Medical University" in a lesser frequency.

Most popular intervention types in "The Affiliated Hospital of Xuzhou Medical University" are "Drug" (117 trials), "Biological" (21 trials), "Procedure" (9 trials), "Device" (7 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (23 trials), "Tislelizumab" (8 trials), "Control" (4 trials), "placebo" (4 trials) and "Cisplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Affiliated Hospital of Xuzhou Medical University" are 154 trials for "All" genders, 6 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are 87 active trials in "The Affiliated Hospital of Xuzhou Medical University". 6 are not yet recruiting, 63 are recruiting, 14 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 32 completed trials in The Affiliated Hospital of Xuzhou Medical University, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in The Affiliated Hospital of Xuzhou Medical University, 19 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 63 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 15 trials, and there were also 22 trials that are defined as “Not Applicable".